Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Antiviral Agents therapeutic use"" wg kryterium: Temat


Czasopismo naukowe
Tytuł:
Inferior cure rate in pilot study of 4‐week glecaprevir/pibrentasvir treatment with or without ribavirin of chronic hepatitis C
Autorzy:
Lone W. Madsen
Peer B. Christensen
Ulrik Fahnøe
Martin S. Pedersen
Jens Bukh
Anne Øvrehus
Pokaż więcej
Temat:
Hepatology
drug resistance
glecaprevir
hepatitis C virus
pibrentasvir
retreatment
ribavirin
Benzimidazoles
Hepacivirus/genetics
Humans
Cyclopropanes
Genotype
Quinoxalines/therapeutic use
Lactams, Macrocyclic
Aminoisobutyric Acids
Pilot Projects
Sulfonamides
Antiviral Agents/therapeutic use
Pyrrolidines
Hepatitis C, Chronic/drug therapy
Proline/analogs & derivatives
Sustained Virologic Response
Leucine/analogs & derivatives
Ribavirin/therapeutic use
Źródło:
Wulff Madsen, L, Brehm Christensen, P, Fahnøe, U, Pedersen, M S, Bukh, J & Øvrehus, A 2021, ' Inferior cure rate in pilot study of 4-week glecaprevir/pibrentasvir treatment with or without ribavirin of chronic hepatitis C ', Liver International, vol. 41, no. 11, pp. 2601-2610 . https://doi.org/10.1111/liv.14991
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ed33771b24d3d7be32c1164eb6bccdd
https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14991
Tytuł:
COVID-19 infection in first trimester of pregnancy marked by a liver cytolysis in a woman previously treated by hydroxychloroquine for repeated implantation failure: a case report
Autorzy:
Pierre Oger
F. Lamazou
Lucie Delaroche
A. Guerin
V. Letouzey
V. Place
S. Octernaud
P. Descamps
Paul Calès
R. Dieli-crimi
Pokaż więcej
Temat:
COVID-19
First trimester
Hepatic cytolysis
Liver
Case report
Hydroxychloroquine
lcsh:Infectious and parasitic diseases
lcsh:RC109-216
MESH: Antiviral Agents / therapeutic use
MESH: Betacoronavirus* / genetics
MESH: Betacoronavirus* / isolation & purification
MESH: Coronavirus Infections / pathology
MESH: Hydroxychloroquine / therapeutic use
MESH: Liver / pathology
MESH: Pneumonia, Viral / pathology
MESH: Pregnancy Complications, Infectious / pathology
MESH: Transaminases / metabolism
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases
[SDV.SP.MED]Life Sciences [q-bio]/Pharmaceutical sciences/Medication
[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics
Infectious Diseases
Obstetrics
medicine.medical_specialty
medicine
Differential diagnosis
Medical microbiology
Fetus
Toxicity
business.industry
business
Intrauterine growth restriction
medicine.disease
Nausea
medicine.symptom
Pregnancy
medicine.drug
Źródło:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-5 (2020)
BMC Infectious Diseases
BMC Infectious Diseases, BioMed Central, 2020, 20, pp.845. ⟨10.1186/s12879-020-05551-0⟩
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::155715d3817069f47fe66d607a7f93e2
http://link.springer.com/article/10.1186/s12879-020-05551-0
Tytuł:
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Autorzy:
Paul E. Oberstein
Jared D. Acoba
Catherine Curran
Narjust Duma
Maryam B. Lustberg
Fiona Busser
Vadim S. Koshkin
John C. Leighton
Ruben A. Mesa
Susie Owenby
Petros Grivas
Sarah Nagle
Jessica K. Altman
Michael H. Bar
Clarke A. Low
David D. Chism
Shuchi Gulati
Tian Zhang
Grace Glace
Merry Jennifer Markham
Gilberto Lopes
Gregory J. Riely
Tyler Masters
Andy Futreal
Archana Ajmera
George D. Demetri
Nathan A. Pennell
Eneida R. Nemecek
Chintan Shah
Catherine Stratton
Marc A. Rovito
Andrew Schmidt
Briana Barrow
Chih-Yuan Hsu
Babar Bashir
Mark E. Dailey
Elizabeth Wulff-Burchfield
Terence D. Rhodes
Carla Casulo
Philip E. Lammers
Thorvardur R. Halfdanarson
Susan Yackzan
Adam J. Olszewski
Axel Grothey
Abdul-Hai Mansoor
Neeta K. Venepalli
Gayathri Nagaraj
Ardaman Shergill
Wenxin (Vincent) Xu
Ang Li
Rana R. McKay
Nizar M. Tannir
Saurabh Dahiya
Alicia K. Morgans
Umit Topaloglu
Daniel W. Bowles
Pamela C Egan
Robert L. Rice
Balazs Halmos
Angelo Cabal
Sanjay G. Revankar
Antonio Giordano
Jill S. Barnholtz-Sloan
Geoffrey Shouse
Yu Shyr
Arielle Elkrief
Jonathan Riess
Brian I. Rini
Sarah A Wall
Salma K. Jabbour
Paolo Caimi
Rosemary Zacks
John M. Nakayama
Mark A. Lewis
Kent Hoskins
Albert C. Yeh
Barbara B. Logan
Grace Shaw
Rohit K. Jain
Bryan Faller
Jeanna Knoble
Rulla M. Tamimi
Sanjay Shete
Leyre Zubiri
Heather H. Nelson
Rawad Elias
Firas Wehbe
Deborah B Doroshow
Ahmad Daher
Sanjay Mishra
Amit Verma
Karen Vega-Luna
Gary H. Lyman
Ryan Nguyen
Sandeep H. Mashru
Patricia LoRusso
Aakash Desai
Amit Sanyal
Mansi R. Shah
Arturo Loaiza-Bonilla
Erin A. Gillaspie
John Deeken
Christopher McNair
Corrie A. Painter
Salvatore Del Prete
Lori J. Rosenstein
Praveen Vikas
Pramod K. Srivastava
Syed A. Ahmad
Paul Fu
Anup Kasi
Shannon K. McWeeney
Solange Peters
Anne H. Angevine
Daniel G. Stover
Michelle Marcum
Lidia Schapira
Vikram Narayan
M. Wasif Saif
Dimpy P. Shah
Jordan Kharofa
John Philip
Pier Vitale Nuzzo
Jeremy L. Warner
Ryan Monahan
Christopher R. Friese
Christopher A. Lemmon
Dawn L. Hershman
Andrea J. Zimmer
Navid Hafez
Julie Tsu-Yu Wu
Alokkumar Jha
Eric H. Bernicker
Daniel Castellano
Kaitlin Kelleher
Jamie Stratton
Genevieve M. Boland
Elizabeth A. Griffiths
Marcus Messmer
Ziad Bakouny
Sara Matar
Stephanie Berg
D.B. Flora
Anthony P. Gulati
Donald C. Vinh
Ali Raza Khaki
Zhuoer Xie
Xuanyi Li
Rohit Bishnoi
Nilo Azad
Orestis A. Panagiotou
Douglas B. Johnson
Maheen Abidi
Tanios Bekaii-Saab
Sabitha Prabhakaran
Toni K. Choueiri
Shilpa Gupta
K.M. Steve Lo
Mary Salazar
Carmen C. Solorzano
Erin Cook
David M. Gill
Justin Shaya
Jessica M. Clement
Mary F. Mulcahy
Alice Y. Zhou
Sumit A. Shah
Paul L. Weinstein
Bertrand Routy
Prakash Peddi
Karen Stauffer
Mark Bonnen
Vivek Subbiah
Jack West
Alvaro G. Menendez
Mary M. Pasquinelli
Dimitrios Farmakiotis
Susan Van Loon
Kerry L. Reynolds
Michael A. Thompson
Sarah Mushtaq
Colleen Lewis
Donna R Rivera
Sandy DiLullo
Aditya Bardia
Keith Stockerl-Goldstein
Michael Gurley
John A. Steinharter
Rimma Belenkaya
Roy S. Herbst
Suki Subbiah
James L. Chen
Gerald Batist
Nicole M. Kuderer
Jarushka Naidoo
Oscar K. Serrano
Monika Joshi
Theresa M. Carducci
Harry Menon
Michael J Glover
Jorge A. Garcia
Peter Paul Yu
Leslie A. Fecher
Mateo Bover Larroya
Samuel M. Rubinstein
Heloisa P. Soares
Justin F. Gainor
Candice Schwartz
Matthew Puc
Trisha Wise-Draper
Daruka Mahadevan
Lisa Weissmann
Emily Hsu
Matthew D. Galsky
Hina Khan
Cameron Rink
Christine Bestvina
Matthias Weiss
Eli Van Allen
Gabrielle Bouchard
Lane R. Rosen
Neeraj Agarwal
Nathaniel Bouganim
Lawrence E. Feldman
William I. Wood
Amelie G. Ramirez
Young Soo Rho
Mehmet Asim Bilen
Janice M. Mehnert
Jessica Hawley
Rachel P. Rosovsky
Joerg Rathmann
Amit Kulkarni
Catherine Handy Marshall
Julie Fu
Elizabeth V. Robilotti
Pokaż więcej
Temat:
General Medicine
Cancer
medicine.disease
medicine
Cohort study
Prognostic variable
business.industry
business
Cause of death
Comorbidity
Odds ratio
Cohort
Internal medicine
medicine.medical_specialty
Clinical endpoint
Aged
Antiviral Agents/therapeutic use
Azithromycin/therapeutic use
Betacoronavirus
Cause of Death
Coronavirus Infections/drug therapy
Coronavirus Infections/epidemiology
Coronavirus Infections/mortality
Databases, Factual
Female
Humans
Hydroxychloroquine/therapeutic use
Male
Middle Aged
Neoplasms/epidemiology
Neoplasms/mortality
Neoplasms/therapy
Pandemics
Pneumonia, Viral/drug therapy
Pneumonia, Viral/epidemiology
Pneumonia, Viral/mortality
Prognosis
Risk Factors
Article
Źródło:
The Lancet
Lancet, vol. 395, no. 10241, pp. 1907-1918
Lancet (London, England)
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21d89f8d57a74fe5fc8b244572e6a776
https://api.elsevier.com/content/article/PII:S0140673620311879?httpAccept=text/xml
Tytuł:
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
Autorzy:
Yahya Mahamat-Saleh
Nathan Peiffer-Smadja
Mathieu E. Rebeaud
Matthieu Mulot
Thibault Fiolet
Anthony Guihur
Pokaż więcej
Temat:
Infectious Diseases
Microbiology (medical)
General Medicine
Azithromycin
Chloroquine
Coronavirus
Coronavirus disease 2019
Hydroxychloroquine
Meta-analysis
Mortality
Severe acute respiratory syndrome coronavirus 2
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Systematic Review
Antiviral Agents/therapeutic use
Azithromycin/therapeutic use
Bayes Theorem
Bias
COVID-19/drug therapy
COVID-19/mortality
COVID-19/virology
Chloroquine/therapeutic use
Drug Repositioning
Humans
Hydroxychloroquine/therapeutic use
Risk
SARS-CoV-2/drug effects
SARS-CoV-2/pathogenicity
Standard of Care
Survival Analysis
Randomized controlled trial
law.invention
law
medicine.drug
medicine
business.industry
business
Relative risk
Mortality rate
Internal medicine
medicine.medical_specialty
Cochrane Library
Observational study
Źródło:
Clinical Microbiology and Infection
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2021, 27 (1), pp.19-27. ⟨10.1016/j.cmi.2020.08.022⟩
Clinical microbiology and infection, vol. 27, no. 1, pp. 19-27
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13df64d9848e6ea0ba2dc8f6f994ba5b
Tytuł:
Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
Autorzy:
Sophie Juul
Emil Eik Nielsen
Joshua Feinberg
Faiza Siddiqui
Caroline Kamp Jørgensen
Emily Barot
Johan Holgersson
Niklas Nielsen
Peter Bentzer
Areti Angeliki Veroniki
Lehana Thabane
Fanlong Bu
Sarah Klingenberg
Christian Gluud
Janus Christian Jakobsen
Pokaż więcej
Temat:
Medicine
Science
Multidisciplinary
Adenosine Monophosphate/analogs & derivatives
Adrenal Cortex Hormones/therapeutic use
Alanine/analogs & derivatives
Antibodies, Monoclonal, Humanized/therapeutic use
Antiviral Agents/therapeutic use
Bromhexine/therapeutic use
COVID-19/drug therapy
Clinical Trials as Topic
Expectorants/therapeutic use
Humans
Immunoglobulins, Intravenous/therapeutic use
Respiration, Artificial
SARS-CoV-2/drug effects
Treatment Outcome
Research Article
Research and Analysis Methods
Mathematical and Statistical Techniques
Statistical Methods
Metaanalysis
Physical Sciences
Mathematics
Statistics
Research Design
Clinical Research Design
Adverse Events
Medicine and Health Sciences
Epidemiology
Medical Risk Factors
Biology and Life Sciences
Biochemistry
Proteins
Interferons
Engineering and Technology
Industrial Engineering
Quality Control
Visual Inspection
Medical Conditions
Infectious Diseases
Viral Diseases
Covid 19
Database and Informatics Methods
Database Searching
Pharmacology
Drugs
Colchicine
Źródło:
PLoS ONE, Vol 16, Iss 3, p e0248132 (2021)
Juul, S, Nielsen, E E, Feinberg, J, Siddiqui, F, Jørgensen, C K, Barot, E, Holgersson, J, Nielsen, N, Bentzer, P, Veroniki, A A, Thabane, L, Bu, F, Klingenberg, S, Gluud, C & Jakobsen, J C 2021, ' Interventions for treatment of COVID-19 : Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project) ', PLOS ONE, vol. 16, no. 3, e0248132 . https://doi.org/10.1371/journal.pone.0248132
PLoS ONE
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d98f0fff3a813dde86f143ac6b1259d
https://doaj.org/article/b2507f15905f41fa8aead3ceb941a1e0
Tytuł:
Izvanbolničke upale pluća u djece Preporuke hrvatskog društva za pedijatrijsku pulmologiju Hrvatskoga liječničkog zbora
Autorzy:
Pavlov, Neven
Banac, Srđan
Čepin Bogović, Jasna
Goić Barišić, Ivana
Čičak, Biserka
Kljaić, Nada
Kljaić Bukvić, Blaženka
Mihatov Štefanović, Iva
Pavić, Ivan
Radonić, Marija
Roglić, Srđan
Rožmanić, Vojko
Tešović, Goran
Tješić Drinković, Dorijan
Turkalj, Mirjana
Pokaż więcej
Temat:
IZVANBOLNIČKE INFEKCIJE – dijagnoza, farmakoterapija, mikrobiologija, prevencija, virologija
BAKTERIJSKA UPALA PLUĆA – dijagnoza, farmakoterapija, prevencija
VIRUSNA UPALA PLUĆA – dijagnoza, farmakoterapija, prevecija
PROTUBAKTERIJSKI LIJEKOVI – terapijska uporaba
PROTUVIRUSNI LIJEKOVI – terapijska uporaba
CIJEPLJENJE
PEDIJATRIJA
PULMOLOGIJA
DJECA
HRVATSKA
SMJERNICE
COMMUNITY-ACQUIRED INFECTIONS – diagnosis, drug therapy, microbiology, prevention and control, virology
PNEUMONIA, BACTERIAL – diagnosis, drug therapy, prevention and control
PNEUMONIA, VIRAL – diagnosis, drug therapy, prevention and control
ANTI-BACTERIAL AGENTStherapeutic use
ANTIVIRAL AGENTStherapeutic use
VACCINATION
PEDIATRICS
PULMONARY MEDICINE
CHILD
CROATIA
PRACTICE GUIDELINES AS TOPIC
BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Pedijatrija
BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Pediatrics
BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Interna medicina
BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Internal Medicine
Źródło:
Liječnički vjesnik
Volume 143
Issue 9-10
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1b8e80ded9341c5f584a77ff1fbadfa8
https://repository.medri.uniri.hr/islandora/object/medri:4776
Tytuł:
Identification of SARS-CoV-2 Polymerase and Exonuclease Inhibitors and Novel Methods for Single-Color Fluorescent DNA Sequencing by Synthesis
Autorzy:
Wang, Xuanting
Pokaż więcej
Temat:
Chemical engineering
FOS: Chemical engineering
COVID-19 (Disease)--Treatment
Nucleotide sequence
Color codes
Sofosbuvir
RNA polymerases--Inhibitors
Antiviral agents--Therapeutic use
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_________::416914fdb6e700f479dda14d129ddd45
Tytuł:
Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics
Autorzy:
Stanilas Faguer
Rosine Guimbaud
Vincent Minville
Didier Concordet
Marlène Murris
Stéphanie Ruiz
Véronigue Duhalde
Jean-Marie Conil
Peggy Gandia
Karen Delavigne
Yves Rolland
Frédéric Eyvrard
Jean-Michel Mansuy
Stein Silva Sifontes
Pierre Delobel
Bernard Georges
Jacques Izopet
Guillaume Martin-Blondel
Grégory Pugnet
Pokaż więcej
Temat:
dosage regimens
population pharmacokinetic modeling
drug monitoring
hydroxychloroquine
COVID-19
kinetics
pharmacokinetics
MESH: Antiviral Agents* / therapeutic use
MESH: COVID-19* / drug therapy
MESH: Humans
MESH: Hydroxychloroquine / therapeutic use
MESH: Kinetics
MESH: SARS-CoV-2
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Infectious Diseases
Microbiology (medical)
2019-20 coronavirus outbreak
Medicine
business.industry
business
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Pharmacology
Hydroxychloroquine
medicine.drug
Pharmacokinetics
Coronavirus disease 2019 (COVID-19)
[SDV.SP.MED]Life Sciences [q-bio]/Pharmaceutical sciences/Medication
[SDV]Life Sciences [q-bio]
[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences
Źródło:
Clinical Infectious Diseases
Clinical Infectious Diseases, Oxford University Press (OUP), 2020, 71 (11), pp.2962-2964. ⟨10.1093/cid/ciaa558⟩
Clinical Infectious Diseases, Oxford University Press (OUP), 2020, ⟨10.1093/cid/ciaa558⟩
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d888ada4af45710e3a7a8801b9bc028
https://hal-univ-tlse3.archives-ouvertes.fr/hal-03167732
Tytuł:
Possible treatment and strategies for COVID-19:review and assessment
Autorzy:
Trivedi, N
Verma, A
Kumar, D
Pokaż więcej
Temat:
Adenosine Monophosphate/analogs & derivatives
Alanine/analogs & derivatives
Amides/therapeutic use
Anti-Bacterial Agents/therapeutic use
Anti-Inflammatory Agents/therapeutic use
Antibodies, Monoclonal, Humanized/therapeutic use
Antibodies, Neutralizing/therapeutic use
Antiparasitic Agents/therapeutic use
Antiviral Agents/therapeutic use
COVID-19/drug therapy
COVID-19 Vaccines/therapeutic use
Cannabinoids/therapeutic use
Chloroquine/therapeutic use
Complement Inactivating Agents/therapeutic use
Dexamethasone/therapeutic use
Drug Combinations
Enzyme Inhibitors/therapeutic use
Humans
Hydroxychloroquine/therapeutic use
Immunization, Passive
Indoles/therapeutic use
Interferons/therapeutic use
Ivermectin/therapeutic use
Lopinavir/therapeutic use
Pyrazines/therapeutic use
Ritonavir/therapeutic use
SARS-CoV-2
Teicoplanin/therapeutic use
Tetracyclines/therapeutic use
Thiazoles/therapeutic use
Źródło:
Trivedi, N, Verma, A & Kumar, D 2020, ' Possible treatment and strategies for COVID-19 : review and assessment ', European review for medical and pharmacological sciences, vol. 24, no. 23, pp. 12593-12608 . https://doi.org/10.26355/eurrev_202012_24057
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=od______3818::67e7992fccea44928baf508273a43c1b
https://www.research.manchester.ac.uk/portal/en/publications/possible-treatment-and-strategies-for-covid19(6314579b-9634-4e58-a745-0862e56f0f85).html
Tytuł:
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial
Autorzy:
Carla Schaubhut
François Chappuis
Laurent A. Decosterd
Manuel Battegay
Diego O. Andrey
Julien Salamun
Giovanni Jacopo Nicoletti
Moritz Back
Laurent Kaiser
Frederique A. Jacquerioz
Thomas Agoritsas
Annalisa Marinosci
Benjamin Meyer
Idris Guessous
Niklaus Daniel Labhardt
Silvio Ragozzino
Marcel Stoeckle
Hervé Spechbach
Thomas V. Perneger
Simon Fuchs
Alexandra Calmy
Dan Lebowitz
Mikaela Smit
Pokaż więcej
Temat:
Infectious Diseases
epidemiology
preventive medicine
clinical trials
COVID-19
General Medicine
Relative risk reduction
Asymptomatic
medicine.symptom
medicine
business.industry
business
Chemoprophylaxis
Clinical endpoint
Epidemiology
medicine.medical_specialty
Clinical trial portal
Internal medicine
Lopinavir
medicine.drug
Clinical trial
ddc:616
ddc:618
ddc:613
ddc:616.07
Antiviral Agents/therapeutic use
Betacoronavirus
Coronavirus Infections/prevention & control
Drug Combinations
Humans
Lopinavir/therapeutic use
Pandemics/prevention & control
Pneumonia
Viral/prevention & control
Post-Exposure Prophylaxis/methods
Randomized Controlled Trials as Topic
Ritonavir/therapeutic use
SARS-CoV-2
Switzerland
Medicine
Źródło:
BMJ Open
BMJ Open, Vol. 10, No 11 (2020) P. e040110
BMJ Open, Vol 10, Iss 11 (2020)
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a0b8c15189224a375497bca8a021c11
http://europepmc.org/articles/PMC7662450
Tytuł:
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
Autorzy:
Fadnes, Lars T.
Aas, Christer Frode
Vold, Jørn Henrik
Ohldieck, Christian
Leiva, Rafael Alexander
Chalabianloo, Fatemeh
Skurtveit, Svetlana
Lygren, Ole Jørgen
Dalgård, Olav
Vickerman, Peter
Midgard, Håvard
Løberg, Else-Marie
Johansson, Kjell Arne
for the INTRO-HCV Study Group
Pokaż więcej
Temat:
Chronic hepatitis C
Opiate substitution treatment
Integrated health care
Substance abuse treatment centres
lcsh:Infectious and parasitic diseases
lcsh:RC109-216
Infectious Diseases
Substance abuse
medicine.disease
medicine
Outpatient clinic
Quality of life
Clinical trial
Intensive care medicine
medicine.medical_specialty
Standard treatment
Opiate Substitution Treatment
Referral
Randomized controlled trial
law.invention
law
business.industry
business
Study Protocol
Aftercare
Antiviral Agents/therapeutic use
Cost-Benefit Analysis
Counseling
Delivery of Health Care, Integrated/methods
Female
Hepacivirus/genetics
Hepatitis C/drug therapy
Humans
Male
Norway
Polymerase Chain Reaction
Quality of Life
Recurrence
Substance Abuse, Intravenous/complications
Sustained Virologic Response
Treatment Adherence and Compliance
Źródło:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Infectious Diseases
Lim, A G 2019, ' Integrated treatment of hepatitis C virus infection among people who inject drugs : study protocol for a randomised controlled trial (INTRO-HCV) ', BMC Infectious Diseases, vol. 19, no. 1, pp. 943 . https://doi.org/10.1186/s12879-019-4598-7
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1f306d442ea3e9249dc76b5005b9b93
http://link.springer.com/article/10.1186/s12879-019-4598-7
Tytuł:
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
Autorzy:
Sepideh Sadegh
Jan Baumbach
Andreas Pichlmair
Markus List
Josch K. Pauling
David B. Blumenthal
Alexey Stukalov
Mhaned Oubounyt
Julian Matschinske
Reza Nasirigerdeh
Marisol Salgado-Albarrán
Gihanna Galindez
Tim Rose
Tim Kacprowski
Nina K. Wenke
Julian Späth
Kevin Yuan
Pokaż więcej
Temat:
General Physics and Astronomy
General Biochemistry, Genetics and Molecular Biology
General Chemistry
Viral life cycle
Systems biology
Systems medicine
Computer science
Drug repositioning
Infectious disease (medical specialty)
Computational biology
Coronavirus
medicine.disease_cause
medicine
Network medicine
Interactome
lcsh:Science
lcsh:Q
Quantitative Biology - Molecular Networks
Algorithms
Antiviral Agents/therapeutic use
Betacoronavirus/drug effects
COVID-19
Computer Simulation
Coronavirus Infections/drug therapy
Drug Repositioning/methods
Host Microbial Interactions/physiology
Humans
Internet
Pandemics
Pneumonia, Viral/drug therapy
Protein Interaction Maps
SARS-CoV-2
Virus Attachment/drug effects
Article
Network topology
Target identification
Software
Viral infection
Science
viruses
Źródło:
Nature Communications, Vol 11, Iss 1, Pp 1-9 (2020)
Sadegh, S, Matschinske, J, Blumenthal, D B, Galindez, G, Kacprowski, T, List, M, Nasirigerdeh, R, Oubounyt, M, Pichlmair, A, Rose, T D, Salgado-Albarrán, M, Späth, J, Stukalov, A, Wenke, N K, Yuan, K, Pauling, J K & Baumbach, J 2020, ' Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing ', Nature Communications, vol. 11, 3518 . https://doi.org/10.1038/s41467-020-17189-2
Nature Communications
Opis pliku:
application/pdf
Dostępność:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edfbb6d2bc5c8af39f535ca0f87d40e5
http://www.nature.com/articles/s41467-020-17189-2.pdf

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz